# Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/discordance-of-immunotherapy-response-predictive-biomarkers-between-primary/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yutian Zou,Xiaoqian Hu,Shaoquan Zheng,Anli Yang,Xing Li,Hailin Tang,Yanan Kong,Xiaoming Xie |
| Citations | 95 |
| DOI | 10.1016/j.ebiom.2020.103137 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.thelancet.com/article/S2352396420305132/pdf |
| OpenAlex ID | https://openalex.org/W3113168343 |
| PMID | 33310681 |
| Type | review |
| Year | 2020 |

## Paper authors

- [Xiaoming Xie](https://scholariq.org/researchers/xiaoming-xie/)

## Paper journal

- [EBioMedicine](https://scholariq.org/journals/ebiomedicine/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)
- [Ferroptosis and cancer prognosis](https://scholariq.org/topics/ferroptosis-and-cancer-prognosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.